Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT03030885 · COMPLETED
Trial details
- NCT number
- NCT03030885
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2019-04-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.